Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
Clinical trial NCT01831726 · COMPLETED
Trial details
- NCT number
- NCT01831726
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.